University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Mechanisms of Action of Acetaminophen

Not Applicable

Completed

Conditions: Myocardial Infarction
Arthritis

Interventions: Drug: Aspirin First
Drug: Acetaminophen 1000 mg/d
Drug: Acetaminophen 4000 mg/d
Drug: Aspirin Last
Drug: Ibuprofen 800 mg/d

First Posted Date: 2008-03-31

Last Posted Date: 2019-12-03

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 55

Registration Number: NCT00646906

Locations: 🇺🇸
Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania, United States

Chamomile Therapy for Generalized Anxiety

Phase 4

Completed

Conditions: Generalized Anxiety Disorder

Interventions: Dietary Supplement: Chamomile Extract
Other: Placebo

First Posted Date: 2008-03-28

Last Posted Date: 2009-12-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 61

Registration Number: NCT00645983

Locations: 🇺🇸
Depression Research Unit, Universityof Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States

Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples

Not Applicable

Completed

Conditions: HIV Infections
Sexually Transmitted Disease

Interventions: Behavioral: Eban HIV/STD Risk Reduction Intervention
Behavioral: Eban Health Promotion Intervention

First Posted Date: 2008-03-26

Last Posted Date: 2014-01-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1070

Registration Number: NCT00644163

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 1 locations

Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression

Phase 2

Completed

Conditions: Depression

Interventions: Drug: ADAM SPECT plus No Therapy
Drug: ADAM SPECT plus Cognitive Therapy

First Posted Date: 2008-03-21

Last Posted Date: 2020-04-16

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 30

Registration Number: NCT00641108

Locations: 🇺🇸
Depression Research Unit - University of Pennsylvania, Philadelphia, Pennsylvania, United States

Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents

Not Applicable

Completed

Conditions: Sexually Transmitted Diseases
HIV Infections

Interventions: Behavioral: Abstinence-only HIV/STD risk-reduction intervention
Behavioral: Safer-sex-only HIV/STD risk-reduction intervention
Behavioral: Long comprehensive HIV/STD risk-reduction intervention
Behavioral: Health promotion control intervention
Behavioral: Short comprehensive HIV/STD risk-reduction intervention

First Posted Date: 2008-03-21

Last Posted Date: 2017-12-13

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 662

Registration Number: NCT00640653

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance

Phase 2

Completed

Conditions: Hypercholesterolemia
Statin-Associated Myopathy

Interventions: Drug: Pravastatin
Dietary Supplement: Red Yeast Rice
Behavioral: Lifestyle modification program

First Posted Date: 2008-03-20

Last Posted Date: 2010-01-18

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 43

Registration Number: NCT00639223

Locations: 🇺🇸
Chestnut Hill Hospital, Philadelphia, Pennsylvania, United States

Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)

Not Applicable

Completed

Conditions: Cutaneous Lupus Erythematosus (CLE)

Interventions: Drug: Lenalidomide

First Posted Date: 2008-03-12

Last Posted Date: 2023-02-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 5

Registration Number: NCT00633945

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Department of Dermatology, Philadelphia, Pennsylvania, United States

Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder

Phase 4

Completed

Conditions: Menopause
Depression

Interventions: Drug: MDD diagnosis and Estrogen treatment
Drug: MDD diagnosis and Fluoxetine treatment
Drug: MDD diagnosis with both Estrogen and Fluoxetine treatment
Drug: No depression and estrogen treatment

First Posted Date: 2008-02-29

Last Posted Date: 2017-06-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 18

Registration Number: NCT00626340

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Testing Strategies to Improving Warfarin Adherence

Not Applicable

Completed

Conditions: Atrial Fibrillation
Deep Venous Thrombosis
Dilated Cardiomyopathies

Interventions: Behavioral: Lottery arm (Lottery and Med-eMonitor)
Behavioral: Non-Lottery (Med-eMonitor only)

First Posted Date: 2008-02-22

Last Posted Date: 2009-12-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 101

Registration Number: NCT00622102

Locations: 🇺🇸
Hospital of the University of Pennsylvania Anticoagulation Management Center, Philadelphia, Pennsylvania, United States

Combined Treatment for Generalized Anxiety Disorder (GAD)

Phase 2

Completed

Conditions: Generalized Anxiety Disorder

Interventions: Behavioral: Cognitive Behavioral Therapy
Drug: Venlafaxine XR

First Posted Date: 2008-02-21

Last Posted Date: 2017-02-16

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 69

Registration Number: NCT00620776

Locations: 🇺🇸
University of Pennsylvania, 3535 Market Street, Suite 650, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy